CY752A - Pharmaceutical preparations having an adrenocorticotropic activity - Google Patents

Pharmaceutical preparations having an adrenocorticotropic activity

Info

Publication number
CY752A
CY752A CY75274A CY75274A CY752A CY 752 A CY752 A CY 752A CY 75274 A CY75274 A CY 75274A CY 75274 A CY75274 A CY 75274A CY 752 A CY752 A CY 752A
Authority
CY
Cyprus
Prior art keywords
pharmaceutical preparations
adrenocorticotropic
activity
adrenocorticotropic activity
preparations
Prior art date
Application number
CY75274A
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of CY752A publication Critical patent/CY752A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CY75274A 1967-07-10 1974-08-31 Pharmaceutical preparations having an adrenocorticotropic activity CY752A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH977467 1967-07-10

Publications (1)

Publication Number Publication Date
CY752A true CY752A (en) 1974-08-31

Family

ID=4355521

Family Applications (1)

Application Number Title Priority Date Filing Date
CY75274A CY752A (en) 1967-07-10 1974-08-31 Pharmaceutical preparations having an adrenocorticotropic activity

Country Status (9)

Country Link
US (1) US3632743A (en)
BE (1) BE717820A (en)
CY (1) CY752A (en)
DE (1) DE1767927A1 (en)
FR (2) FR8155M (en)
GB (1) GB1230472A (en)
IE (1) IE32559B1 (en)
MY (1) MY7400210A (en)
NL (1) NL6809695A (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862928A (en) * 1969-07-09 1975-01-28 Akzona Inc Psychopharmacological hexa-peptides containing a d-phenylalanyl residue
US3954975A (en) * 1972-02-17 1976-05-04 Ciba-Geigy Corporation Salts of ACTH-peptides and processes for their manufacture
BE795788A (en) * 1972-02-22 1973-08-22 Akzo Nv PROCESS FOR THE PREPARATION OF PEPTIDES AND PEPTIDE DERIVATIVES AND THEIR USE
US3856770A (en) * 1972-03-08 1974-12-24 Akzona Inc Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
NL175618C (en) * 1972-07-15 1984-12-03 Akzo Nv PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH A PSYCHOPHARMACOLOGICAL ACTION CONTAINING A PEPTIDE OR PEPTIDE DERIVATIVE AND A PROCESS FOR THE PREPARATION OF SUCH PEPTIDES.
DE2254043C2 (en) * 1972-11-04 1985-01-24 Hoechst Ag, 6230 Frankfurt LH-releasing hormone for nasal application
JPS59163313A (en) * 1983-03-09 1984-09-14 Teijin Ltd Peptide hormone composition for nasal administration
US4576646A (en) * 1983-07-06 1986-03-18 Seppic Film-forming compositions for enveloping solid forms, particularly pharmaceutical or food products or seeds, and products obtained, coated with said compositions
IT1218472B (en) * 1985-08-30 1990-04-19 Alfio Bertolini PHARMACEUTICAL COMPOSITIONS INCLUDING ACHT (1-24) FOR THE THERAPEUTIC TREATMENT OF SHOCK STATES AND RESPIRATORY AND CARDIOCIRCULATORY INSUFFICIENCY
IT1204434B (en) * 1986-01-15 1989-03-01 Alfio Bertolini PHARMACEUTICAL COMPOSITIONS INCLUDING ACTH FRAGMENTS FOR THE THERAPEUTIC TREATMENT OF SHOCK STATES AND RESPIRATORY AND CARDIOCIRCULATORY INSUFFICIENCY
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US6932962B1 (en) 1994-12-22 2005-08-23 Astrazeneca Ab Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides
US6264974B1 (en) 1998-07-07 2001-07-24 Salvagnini Italia Spa Buccal and sublingual administration of physostigmine
US6660715B2 (en) * 1998-11-19 2003-12-09 Massachusetts Institute Of Technology Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
CN1738600A (en) * 2002-11-12 2006-02-22 特瓦制药工业有限公司 Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or buccally
DE102006053374A1 (en) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical formulation for aerosols with two or more active substances and at least one surface-active substance
TW200815048A (en) * 2006-06-05 2008-04-01 Verus Pharmaceuticals Inc Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
TW200817049A (en) * 2006-06-05 2008-04-16 Verus Pharmaceuticals Inc Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
JP5763053B2 (en) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Adapter, inhaler and atomizer
JP5658268B2 (en) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
EP2504052B1 (en) 2009-11-25 2022-07-27 Boehringer Ingelheim International GmbH Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (en) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
WO2012130757A1 (en) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
JP6643231B2 (en) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
PL2835146T3 (en) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizer
DK3139984T3 (en) 2014-05-07 2021-07-19 Boehringer Ingelheim Int Atomizer
EP3139979B1 (en) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unit, nebulizer and method
HUE058904T2 (en) 2014-05-07 2022-09-28 Boehringer Ingelheim Int Nebulizer

Also Published As

Publication number Publication date
MY7400210A (en) 1974-12-31
IE32559L (en) 1969-01-10
DE1767927A1 (en) 1971-09-30
FR8156M (en) 1970-08-24
US3632743A (en) 1972-01-04
FR8155M (en) 1970-08-24
IE32559B1 (en) 1973-09-19
BE717820A (en) 1969-01-09
NL6809695A (en) 1969-01-14
GB1230472A (en) 1971-05-05

Similar Documents

Publication Publication Date Title
MY7400210A (en) Pharmaceutical preparations having an adrenocorticotropic activity
IL26065A (en) Dual medicinal vial
IL30165A0 (en) Tablets
IL31125A0 (en) Tablet
USD202467S (en) Pharmaceutical tablets
IL30440A0 (en) Tablet preparation
AU425946B2 (en) Pharmaceutical preparations having an adrenocorticotropic activity
AU4036868A (en) Pharmaceutical preparations having an adrenocorticotropic activity
IL31286A0 (en) 5-nitro-2-furfurylideneamino-oxazolidinone compounds and their preparations
AU427061B2 (en) Pharmaceutical preparations
CA760961A (en) Pharmaceutical preparations
IE31685L (en) Pharmaceutical preparation
YU217368A (en) Viseslojni poluprovodni konstruktivni elemenat
CA766546A (en) Syringe
AU4572468A (en) Pharmaceutical preparations
CA770141A (en) Aminobenzophenone derivatives
IE31147L (en) Injectible preparations
CA752595A (en) Slaughtering
AU428126B2 (en) Pharmaceutical preparations and processes
CA762425A (en) Therapeutic agent
CA29126S (en) Gameboard
AU1137866A (en) Syringe
CA750388A (en) 1-trialcoxy-benzyl piperazines
CA28985S (en) Capsule
IE31206L (en) Pharmaceutical composition